secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001437749-23-033049
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma holds 2023 annual meeting; elects Class II directors, approves advisory pay vote, ratifies auditor
--------------------------------------------------------------------------------

- Christina Kay, Robert Canarick, and William H. Milmoe elected as Class II directors to serve until 2026.
- Non-binding advisory vote on executive compensation approved: 19,964,583 for, 2,510,524 against, 1,715 abstain.
- Ratification of Marcum LLP as independent auditor for FY ending June 30, 2024 passed: 23,762,534 for, 7,281 against.
- Vote results: Kay 20,393,822 for; Canarick 22,301,725 for; Milmoe 22,285,400 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/inbp20231127_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-033049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer